Solid Tumor
7 competing products in clinical development for Solid Tumor.
Pipeline by Phase
Phase 17
All Products (7)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| LY3300054 + Ramucirumab + Abemaciclib + Merestinib + LY3321367 | Eli Lilly | Phase 1 | Completed | 33 |
| LY3435151 + Pembrolizumab | Eli Lilly | Phase 1 | Terminated | 33 |
| LY3415244 | Eli Lilly | Phase 1 | Terminated | 33 |
| NL-201 + Pembrolizumab Injection [Keytruda] | Neurogene | Phase 1 | Completed | 25 |
| ZN-c3 + Carboplatin + Pegylated liposomal doxorubicin + Paclitaxel + Gemcitabine + Bevacizumab | Zentalis Pharmaceuticals | Phase 1 | Recruiting | 25 |
| Azenosertib | Zentalis Pharmaceuticals | Phase 1 | Completed | 25 |
| BBI-825 | Boundless Bio | Phase 1 | Terminated | 25 |